INNV SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of InnovAge Holding Corp. and Encourages Current INNV Stockholders to Contact the Firm

Philadelphia, Pennsylvania--(Newsfile Corp. - May 28, 2022) - Kaskela Law LLC announces that it is investigating InnovAge Holding Corp. (NASDAQ: INNV) ("InnovAge" or the "Company") on behalf of the Company's long-term stockholders.

In March 2021, InnovAge completed its initial public offering ("IPO") of common stock, selling 19 million shares of stock to investors at a price of $21.00 per share.

On September 21, 2021, InnovAge revealed that the Centers for Medicare and Medicaid Services ("CMS") had "determined to freeze new enrollments at [the Company's] Sacramento center based on deficiencies detected in [a recent] audit." Reportedly, such "deficiencies relate to failures to provide covered services, provide accessible and adequate services, manage participants' medical situations, and oversee use of specialists, among others."

Following this news, shares of the Company's stock fell $2.90 per share, or 25% in value, to close at $8.75 per share on September 22, 2021, on unusually heavy trading volume.

Current InnovAge stockholders who purchased or acquired shares of the Company's stock prior to September 21, 2021 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 - 0750, or by email ( or online at , to receive additional information about this investigation and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation.  For additional information about the firm please visit This notice may constitute attorney advertising in certain jurisdictions.


D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 - 1740
(484) 229 - 0750

To view the source version of this press release, please visit